Literature DB >> 9989767

Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?

J C Leung1, P Y Poon, K N Lai.   

Abstract

Immunoglobulin A nephropathy (IgAN) is characterized by raised serum IgA and predominant mesangial IgA deposits of polymeric nature. The abnormal glycosylation of the carbohydrate moieties in the hinge region of the IgA molecule has recently attracted much attention. In this study we investigated the galactosylation and sialylation of monomeric and polymeric IgA1 isolated from patients with IgAN. Total IgA1 in serum samples from patients with IgAN or from healthy controls was isolated with a jacalin-agarose column as jacalin-bound protein (JBP). Monomeric and polymeric IgA1 were distinctly separated by fast protein liquid chromatography. Lectin binding assays were designed to examine the sialylation and the expression of terminal galactose and N-acetyl galactosamine of the O-linked carbohydrate in the hinge region of the IgA molecule. Reduced terminal galactosylation was demonstrated in serum IgA and monomeric IgA1 isolated from patients with IgAN as compared with results in healthy control subjects. However, a reduction in terminal galactosylation was not found in polymeric IgA1 isolated from patients with IgAN. Instead, increased sialylation of IgA1 (alpha2-3 linked to galactose) was demonstrated in polymeric IgA1. This abnormality of IgA1 could bear considerable implication on the pathogenesis of IgAN, because the masking effect of sialic acid may hinder the clearance of polymeric IgA1 by the asialoglycoprotein receptor (ASGP-R) of the liver cells. An increase in the sialylated content would also render the polymeric IgA from patients with IgAN more anionic. These immunochemical properties may contribute to the selective glomerular deposition of polymeric IgA1 in IgAN.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989767     DOI: 10.1016/s0022-2143(99)90008-2

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  11 in total

1.  T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.

Authors:  S R Chintalacharuvu; N U Nagy; N Sigmund; J G Nedrud; M E Amm; S N Emancipator
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 3.  Pathogenesis of IgA nephropathy.

Authors:  Kar Neng Lai
Journal:  Nat Rev Nephrol       Date:  2012-03-20       Impact factor: 28.314

4.  IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.

Authors:  Jan Novak; Leona Raskova Kafkova; Hitoshi Suzuki; Milan Tomana; Karel Matousovic; Rhubell Brown; Stacy Hall; John T Sanders; T Matthew Eison; Zina Moldoveanu; Lea Novak; Zdenek Novak; Richard Mayne; Bruce A Julian; Jiri Mestecky; Robert J Wyatt
Journal:  Nephrol Dial Transplant       Date:  2011-08-09       Impact factor: 5.992

5.  Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.

Authors:  Joseph C K Leung; Sydney C W Tang; Daniel T M Chan; Sing Leung Lui; Kar Neng Lai
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

Review 6.  Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don't Know.

Authors:  Yukako Ohyama; Matthew B Renfrow; Jan Novak; Kazuo Takahashi
Journal:  J Clin Med       Date:  2021-08-05       Impact factor: 4.241

Review 7.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

Review 8.  IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

Authors:  Arun Rajasekaran; Bruce A Julian; Dana V Rizk
Journal:  Am J Med Sci       Date:  2020-10-08       Impact factor: 2.378

9.  Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.

Authors:  Kazuo Takahashi; Milan Raska; Milada Stuchlova Horynova; Stacy D Hall; Knud Poulsen; Mogens Kilian; Yoshiyuki Hiki; Yukio Yuzawa; Zina Moldoveanu; Bruce A Julian; Matthew B Renfrow; Jan Novak
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

10.  Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants.

Authors:  Martina Dicker; Daniel Maresch; Richard Strasser
Journal:  Bioengineered       Date:  2016-06-22       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.